NanoString Technologies (NSTG) Misses Q3 EPS by 20c, provides outlook

NanoString Technologies (NASDAQ: NSTG) reported Q3 EPS of ($0.78), $0.20 worse than the analyst estimate of ($0.58). Revenue for the quarter came in at $48.1 million versus the consensus estimate of $47.21 million.

2023 Outlook

Management updated its financial outlook for 2023 with results now expected as follows:

Total revenue of $175 to $180 million,versus the consensus on $180.9 million and as compared to the previous range of $175 to $185 million

Spatial biology revenue of $96 to $100 million, as compared to the previous range of $100 to $105 million
nCounter revenue, inclusive of all service and other revenue, of $79 to $80 million, as compared to the previous range of $75 to $80 million

Adjusted EBITDA loss of approximately $80 to $85 million, as compared to the previous range of $65 to $75 million

For earnings history and earnings-related data on NanoString Technologies (NSTG) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Tvardi Therapeutics (TVRD) Tops Q2 EPS by 1c
• Reading (RDI) Tops Q2 EPS by 4c